Correlation Between Krystal Biotech and Shuttle Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Krystal Biotech and Shuttle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krystal Biotech and Shuttle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Krystal Biotech and Shuttle Pharmaceuticals, you can compare the effects of market volatilities on Krystal Biotech and Shuttle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krystal Biotech with a short position of Shuttle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krystal Biotech and Shuttle Pharmaceuticals.

Diversification Opportunities for Krystal Biotech and Shuttle Pharmaceuticals

0.21

Correlation Coefficient

Krystal Biotech  Shuttle Pharmaceuticals

Modest diversification

The 3 months correlation between Krystal and Shuttle is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and Shuttle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shuttle Pharmaceuticals and Krystal Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krystal Biotech are associated (or correlated) with Shuttle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shuttle Pharmaceuticals has no effect on the direction of Krystal Biotech i.e., Krystal Biotech and Shuttle Pharmaceuticals go up and down completely randomly.

Pair Corralation between Krystal Biotech and Shuttle Pharmaceuticals

Given the investment horizon of 90 days Krystal Biotech is expected to generate 0.4 times more return on investment than Shuttle Pharmaceuticals. However, Krystal Biotech is 2.51 times less risky than Shuttle Pharmaceuticals. It trades about -0.06 of its potential returns per unit of risk. Shuttle Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest  17,689  in Krystal Biotech on October 26, 2024 and sell it today you would lose (2,183) from holding Krystal Biotech or give up 12.34% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Krystal Biotech  vs.  Shuttle Pharmaceuticals

Krystal Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Krystal Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Shuttle Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Krystal Biotech and Shuttle Pharmaceuticals

The main advantage of trading using opposite Krystal Biotech and Shuttle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krystal Biotech position performs unexpectedly, Shuttle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shuttle Pharmaceuticals will offset losses from the drop in Shuttle Pharmaceuticals' long position.

The idea behind Krystal Biotech and Shuttle Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.